Moreover, MSLN-specific CAR-T cell therapy resulted in the regression of human ovarian cancer in mice, as well as an anticancer response in patients with pancreatic cancer metastases [58]. The gene discussed is MSLN; the disease is familial pancreatic carcinoma.